These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31930325)

  • 1. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report.
    Defayette A; Perrello A; Brewer T; Picano J; Ahmed S
    Am J Health Syst Pharm; 2020 Feb; 77(5):352-355. PubMed ID: 31930325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine for acute baclofen withdrawal.
    Morr S; Heard CM; Li V; Reynolds RM
    Neurocrit Care; 2015 Apr; 22(2):288-92. PubMed ID: 25403764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation.
    Laroche JP
    BMJ Support Palliat Care; 2020 Mar; 10(1):7-9. PubMed ID: 30636205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.
    Darrouj J; Puri N; Prince E; Lomonaco A; Spevetz A; Gerber DR
    Ann Pharmacother; 2008 Nov; 42(11):1703-5. PubMed ID: 18780809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
    Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
    Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder.
    Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O
    J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose baclofen: withdrawal syndrome following abrupt discontinuation.
    Prescrire Int; 2014 Oct; 23(153):241. PubMed ID: 25964972
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
    Vo KT; Horng H; Smollin CG; Benowitz NL
    J Emerg Med; 2017 May; 52(5):680-683. PubMed ID: 27979642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report.
    Hansen CR; Gooch JL; Such-Neibar T
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1468-71. PubMed ID: 17964889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Baclofen withdrawal induced psychosis treated with lorazepam.
    Leandre F; Ginory A
    Aust N Z J Psychiatry; 2019 Feb; 53(2):174. PubMed ID: 30387363
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
    Habibian S; Ahamad K; McLean M; Socias ME
    J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a quality improvement project to standardize pain, agitation, and withdrawal assessments on the use of morphine and midazolam in the Pediatric Intensive Care Unit.
    Kongkiattikul L; Dagenais M; Ruo N; Fontela P; Di Genova T; Zavalkoff S
    Paediatr Anaesth; 2019 Apr; 29(4):322-330. PubMed ID: 30664310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe GHB withdrawal delirium managed with dexmedetomidine.
    Tay EM; Graham RI; Day RO
    Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
    Stewart R; Perez R; Musial B; Lukens C; Adjepong YA; Manthous CA
    Ann Am Thorac Soc; 2016 Feb; 13(2):248-52. PubMed ID: 26799430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Drug Dependence Syndrome to Baclofen Following High-Dose Therapy.
    Hamel Sénécal L; Chrétien B; Jean-Jacques PY; Lelong Boulouard V; Cohen D; Le Boisselier R
    J Clin Psychopharmacol; 2018 Jun; 38(3):277-279. PubMed ID: 29621092
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury.
    Tang JF; Chen PL; Tang EJ; May TA; Stiver SI
    Neurocrit Care; 2011 Aug; 15(1):175-81. PubMed ID: 20198514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen.
    Martinez L; Vorspan F; Declèves X; Azuar J; Fortias M; Questel F; Dereux A; Grichy L; Barreteau H; Bellivier F; Lépine JP; Bloch V
    Fundam Clin Pharmacol; 2018 Apr; 32(2):200-205. PubMed ID: 29224234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management.
    Douglas AF; Weiner HL; Schwartz DR
    J Neurosurg; 2005 Jun; 102(6):1133-6. PubMed ID: 16028775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.